Daily ShareChat: Fisher & Paykel Healthcare
By Jenny Ruth
Fisher & Paykel Healthcare's underlying performance remains strong despite a currency-related downgrade in earnings, says Forsyth Barr analyst Guy Hallwright.
The company has changed its currency assumption from 67 US cents to 74 cents for its second half and cut its earnings guidance by $10 million to between $65 million and $70 million.
"Guidance at the beginning of the year assumed a 60 cents rate, which would imply a $25 million to $30 million downgrade," Hallwright says. "A revision of only $10 million indicates that the underlying buisiness is performing better than expected."
Fisher & Paykel's first-half net profit rose 31% to $37 million.
The company has a strong growth outlook in both its obstructive sleep apnoea business (whose underlying sales rose 20% in the first half) and its respiratory and acute care products (whose first-half sales were up 14%, adjusted for $10 million in one-off sales), Hallwright says.
Expansion into new segments could potentially triple the company's addressable market, he says.
Still, Fisher & Paykel shares already trade on fairly high multiples and a lower currency is needed for the shares to perform strongly from here, he says. Hallwright is expecting a strong New Zealand dollar will persist through 2011. "With less hedging in place, this will impact profits."
BROKER CALL: Forsyth Barr rate FPH as accumulate.
Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.
Comments from our readers
No comments yet Add your comment:
Related News
F&P Healthcare projects flat earnings Daily ShareChat: Fisher & Paykel Healthcare Daily ShareChat: Fisher and Paykel Healthcare Daily ShareChat: Fisher and Paykel Healthcare F&P Healthcare posts 15% gain in profit Daily ShareChat: Fisher & Paykel Healthcare F&P Healthcare commits to third Auckland building as part of $33M spending plan F&P Healthcare humidification products will drive earnings, Morningstar says Record profit for Fisher & Paykel Healthcare - outlook strong F&P Healthcare trims $23m of debt
NZX Annoucements for FPH
|
|
Fisher & Paykel Healthcare Corporation Limited Ord Shares
Current quote:
FPH $2.98
Quotes delayed 20 minutes
Price when article published: $3.15
Previous News
Sharemarket News By Email
Stock Quote
At a Glance
| NZX 50 Index |
3093.58 |
 |
11.10 |
| S&P/ASX 200 |
4532.70 |
 |
0.00 |
| Dow Jones Industrials |
10320.10 |
 |
50.60 |
Comment & Analysis
|
“
The little theme of this week’s newsletter is about looking ahead at the property market and what is happening. Pondering the market is something we often do and it is worth addressing again as there is so much uncertainty and change.
While the news has been pretty gloomy and the housing market appears to be dead, [...]
”
The Landlord More »
|
|
|
|


NZX 15 Index
NZX Announcements
|